Urology Surgical Instrument Market Industry Demand, Share Status, New Technology and Growth Opportunities by 2023– P&S Intelligence
The market is majorly being driven by increasing prevalence of urinary tract infections (UTIs) in women, surging geriatric population, and rising prevalence of benign prostatic hyperplasia (BPH) procedures.
On the basis of product, the market has been categorized into consumables and accessories, urology endoscopes, endovision systems, and peripheral instruments. The consumables and accessories category is predicted to lead the urology surgical instrument market, both in terms of size and growth. The category contributed a 45.3% share in the global market in 2017 and is expected to progress at a CAGR of 9.1% during the forecast period. This leading position is mainly attributable to the high use of guidewires, stone basket, stents, catheters and dilator sets in urology surgery.
Download Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/urology-surgical-instrument-market/report-sample
These surgical instruments find application for the treatment of chronic kidney disease (CKD), urinary stone, BPH, urinary incontinence (UI) and pelvic organ prolapse (POP), oncology and other disorders (erectile dysfunction and hernia). Urology surgical instruments are widely used for the treatment of CKDs due to their increasing prevalence globally as compared to other disorders, and held the largest share in the urology surgical instrument market. According to Centers for Disease Control and Prevention (CDC), 30 million people or 15% of U.S. adults were estimated to have CKDs in 2017.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=urology-surgical-instrument-market
Due to increasing GDP, the countries in the region are witnessing growing demand of these surgical instruments. According to the World Bank, the GDP per capita of India increased from $1,345.8 in 2010 to $1,709.4 in 2016. A similar trend has been observed for other developing countries as well, such as Papua New Guinea, Philippines, and Indonesia, thus leading to the growth of the APAC urology surgical instrument market.
In December 2017, Coloplast A/S entered into a definitive agreement to acquire SAS Lilial (Lilial), a privately owned French catheter and ostomy supplier, for a cash consideration of $41.7 million (€35.5 million). The transaction was closed in January 2018. The acquisition was aimed at providing further access to payers and strengthening Coloplast’s position and offerings in France. Acquisitions taking place in this industry boost the growth of the urology surgical instrument market.
Some of the other key players, other than those mentioned above, operating in the urology surgical instrument industry are Karl Storz GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, Cook Medical LLC, Medtronic plc, Stryker Corporation, Teleflex Incorporated, CONMED Corporation, and CooperSurgical Inc.